SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andrea Diaz De Vivar, Marilyn Dawlett, Jian-Ping Wang, Annie Jack, Yun Gong, Gregg Staerkel, Ming Guo, Clinical Performance of Hybrid Capture 2 Human Papillomavirus Testing for Recurrent High-Grade Cervical/Vaginal Intraepithelial Neoplasm in Patients With an ASC-US Papanicolaou Test Result During Long-Term Posttherapy Follow-up Monitoring, Archives of Pathology & Laboratory Medicine, 2015, 139, 2, 219

    CrossRef

  2. 2
    L. Lecointre, C.-Y. Akladios, G. Averous, F. Lefebvre, E. Baulon, V. Thoma, M. Fender, J.-J. Baldauf, Fiabilité du curetage endocervical après traitement conservateur des néoplasies intraépithéliales du col utérin, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2015, 44, 2, 145

    CrossRef

  3. 3
    Margot H Uijterwaal, Viola MJ Verhoef, Peter JF Snijders, Chris JLM Meijer, Arguments in favor of HPV testing for cervical screening and post-treatment CIN2+ monitoring, Expert Review of Molecular Diagnostics, 2014, 14, 3, 245

    CrossRef

  4. 4
    H. A. Cubie, M. Canham, C. Moore, J. Pedraza, C. Graham, K. Cuschieri, Evaluation of commercial HPV assays in the context of post-treatment follow-up: Scottish Test of Cure Study (STOCS-H), Journal of Clinical Pathology, 2014, 67, 6, 458

    CrossRef

  5. 5
    Borek Sehnal, David Cibula, Jiri Slama, Factors influencing decisions about surgical treatment of cervical precancerous lesions, Expert Review of Anticancer Therapy, 2014, 14, 4, 441

    CrossRef

  6. You have free access to this content6
    Kanako Inaba, Kazunori Nagasaka, Kei Kawana, Takahide Arimoto, Yoko Matsumoto, Tetsushi Tsuruga, Mayuyo Mori-Uchino, Shiho Miura, Kenbun Sone, Katsutoshi Oda, Shunsuke Nakagawa, Tetsu Yano, Shiro Kozuma, Tomoyuki Fujii, High-risk human papillomavirus correlates with recurrence after laser ablation for treatment of patients with cervical intraepithelial neoplasia 3: A long-term follow-up retrospective study, Journal of Obstetrics and Gynaecology Research, 2014, 40, 2
  7. 7
    Chengquan Zhao, Wei Hong, Zaibo Li, Baoying Weng, Millon Amin, R. Marshall Austin, Human papillomavirus testing and cytologic/histopathologic “test of cure” follow-up results after excisional treatment for high-grade cervical intraepithelial neoplasia, Journal of the American Society of Cytopathology, 2014, 3, 1, 15

    CrossRef

  8. 8
    Margot H. Uijterwaal, Mariëlle Kocken, Johannes Berkhof, Ruud L.M. Bekkers, Réne H.M. Verheijen, Theo J.M. Helmerhorst, Chris J.L.M. Meijer, Posttreatment Assessment of Women at Risk of Developing High-Grade Cervical Disease, Journal of Lower Genital Tract Disease, 2014, 18, 4, 338

    CrossRef

  9. 9
    Gong Jin, Zhang LanLan, Chen Li, Zhang Dan, Pregnancy outcome following loop electrosurgical excision procedure (LEEP) a systematic review and meta-analysis, Archives of Gynecology and Obstetrics, 2014, 289, 1, 85

    CrossRef

  10. 10
    Helen Dinkelspiel, Walter Kinney, State of the Science: Cervical cancer screening in transition, Gynecologic Oncology, 2014, 133, 3, 389

    CrossRef

  11. 11
    Anne F. Rositch, Heidi M. Soeters, Tabatha N. Offutt-Powell, Bradford S. Wheeler, Sylvia M. Taylor, Jennifer S. Smith, The incidence of human papillomavirus infection following treatment for cervical neoplasia: A systematic review, Gynecologic Oncology, 2014, 132, 3, 767

    CrossRef

  12. 12
    Fang-Ping Chen, Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm, Taiwanese Journal of Obstetrics and Gynecology, 2013, 52, 4, 475

    CrossRef

  13. 13
    Sidsel S. Barken, Elsebeth Lynge, Erik S. Andersen, Matejka Rebolj, Long-term adherence to follow-up after treatment of cervical intraepithelial neoplasia: nationwide population-based study, Acta Obstetricia et Gynecologica Scandinavica, 2013, 92, 7
  14. 14
    Cheng Yong Wu, Man Yang, Mei Lin, Li Ping Li, Xie Zhen Wen, MTHFR C677T polymorphism was an ethnicity-dependent risk factor for cervical cancer development: evidence based on a meta-analysis, Archives of Gynecology and Obstetrics, 2013, 288, 3, 595

    CrossRef

  15. 15
    J.-J. Baldauf, G. Averous, E. Baulon, V. Thoma, A. Talha-Vautravers, N. Sananes, Y.C. Akladios, Neoplasias intraepiteliales del cuello uterino, EMC - Ginecología-Obstetricia, 2013, 49, 3, 1

    CrossRef

  16. 16
    J.-J. Baldauf, G. Averous, E. Baulon, V. Thoma, A. Talha-Vautravers, N. Sananes, Y.C. Akladios, Néoplasies intraépithéliales du col, EMC - Gynécologie, 2013, 8, 2, 1

    CrossRef

  17. 17
    Nicole Karjane, David Chelmow, New Cervical Cancer Screening Guidelines, Again, Obstetrics and Gynecology Clinics of North America, 2013, 40, 2, 211

    CrossRef

  18. 18
    Attila Lorincz, Alejandra Castanon, Anita Wey Wey Lim, Peter Sasieni, New strategies for human papillomavirus-based cervical screening, Women's Health, 2013, 9, 5, 443

    CrossRef

  19. 19
    &NA;, Practice Bulletin No. 140, Obstetrics & Gynecology, 2013, 122, 6, 1338

    CrossRef

  20. You have free access to this content20
    Debbie Saslow, Diane Solomon, Herschel W. Lawson, Maureen Killackey, Shalini L. Kulasingam, Joanna Cain, Francisco A. R. Garcia, Ann T. Moriarty, Alan G. Waxman, David C. Wilbur, Nicolas Wentzensen, Levi S. Downs, Mark Spitzer, Anna-Barbara Moscicki, Eduardo L. Franco, Mark H. Stoler, Mark Schiffman, Philip E. Castle, Evan R. Myers, American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer, CA: A Cancer Journal for Clinicians, 2012, 62, 3
  21. 21
    Debbie Saslow, Diane Solomon, Herschel W. Lawson, Maureen Killackey, Shalini L. Kulasingam, Joanna M. Cain, Francisco A. R. Garcia, Ann T. Moriarty, Alan G. Waxman, David C. Wilbur, Nicolas Wentzensen, Levi S. Downs, Mark Spitzer, Anna-Barbara Moscicki, Eduardo L. Franco, Mark H. Stoler, Mark Schiffman, Philip E. Castle, Evan R. Myers, American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer, Journal of Lower Genital Tract Disease, 2012, 16, 3, 175

    CrossRef

  22. 22
    Aeli Ryu, Kyehyun Nam, Jeongja Kwak, Jeongsig Kim, Seob Jeon, Early human papillomavirus testing predicts residual/recurrent disease after LEEP, Journal of Gynecologic Oncology, 2012, 23, 4, 217

    CrossRef

  23. 23
    Marc Arbyn, Guglielmo Ronco, Ahti Anttila, Chris J.L.M. Meijer, Mario Poljak, Gina Ogilvie, George Koliopoulos, Pontus Naucler, Rengaswamy Sankaranarayanan, Julian Peto, Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer, Vaccine, 2012, 30, F88

    CrossRef

  24. 24
    Amina Lubrano, Norberto Medina, Virginia Benito, Octavio Arencibia, Juan Miguel Falcón, Laureano Leon, Jesús Molina, Orlando Falcón, Follow-up after LLETZ: a study of 682 cases of CIN 2–CIN 3 in a single institution, European Journal of Obstetrics & Gynecology and Reproductive Biology, 2012, 161, 1, 71

    CrossRef

  25. 25
    Shalini Kulasingam, Laura Havrilesky, Health economics of screening for gynaecological cancers, Best Practice & Research Clinical Obstetrics & Gynaecology, 2012, 26, 2, 163

    CrossRef

  26. 26
    Mariëlle Kocken, Margot H. Uijterwaal, Anton L.M. de Vries, Johannes Berkhof, Johannes C.F. Ket, Theo J.M. Helmerhorst, Chris J.L.M. Meijer, High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: A systematic review and meta-analysis, Gynecologic Oncology, 2012, 125, 2, 500

    CrossRef

  27. 27
    WILLIAM PATRICK SOUTTER, BRONWEN MOSS, KAREN PERRYMAN, MARIA KYRGIOU, KATERINA PAPAKONSTANTINOU, SADAF GHAEM-MAGHAMI, Long-term compliance with follow-up after treatment for cervical intra-epithelial neoplasia, Acta Obstetricia et Gynecologica Scandinavica, 2012, 91, 9
  28. 28
    Aimée R. Kreimer, Mark Schiffman, Rolando Herrero, Allan Hildesheim, Paula González, Robert D. Burk, Carolina Porras, Mark E. Sherman, Franklin Demuth, Li Cheung, Concepción Bratti, Ana Cecilia Rodríguez, Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment, International Journal of Cancer, 2012, 131, 1
  29. 29
    E. Rapiti, M. Usel, I. Neyroud-Caspar, A. Merglen, H.M. Verkooijen, A.T. Vlastos, J.C. Pache, N. Kumar, C. Bouchardy, Omission of excisional therapy is associated with an increased risk of invasive cervical cancer after cervical intraepithelial neoplasia III, European Journal of Cancer, 2012, 48, 6, 845

    CrossRef

  30. 30
    I Kalliala, A Anttila, T Dyba, T Hakulinen, M Halttunen, P Nieminen, Pregnancy incidence and outcome among patients with cervical intraepithelial neoplasia: a retrospective cohort study, BJOG: An International Journal of Obstetrics & Gynaecology, 2012, 119, 2
  31. 31
    Aureli Torné Bladé, José María Bayas Rodríguez, Xavier Castellsagué Piqué, María Castro Sánchez, Enrique García García, Juan Carlos Martínez Escoriza, Luis María Puig-Tintoré, Alfonso Quesada López-Fe, José Antonio Vidart Aragón, Vacunación frente al cáncer de cérvix en mujeres fuera de los programas de vacunación sistemática, con o sin infección por el virus del papiloma humano o lesión cervical. Encuesta de opinión y recomendaciones, Progresos de Obstetricia y Ginecología, 2012, 55, 10

    CrossRef

  32. 32
    Kerri S. Bevis, Joseph R. Biggio, Cervical conization and the risk of preterm delivery, American Journal of Obstetrics and Gynecology, 2011, 205, 1, 19

    CrossRef

  33. 33
    S Ghaem-Maghami, D De-Silva, M Tipples, SJ Lam, K Perryman, WP Soutter, Determinants of success in treating cervical intraepithelial neoplasia, BJOG: An International Journal of Obstetrics & Gynaecology, 2011, 118, 6
  34. 34
    Zongqun Ding, Chunping Jiang, Timothy Shore, Selvan Pather, Christopher Dalrymple, Kenneth Atkinson, Rajmohan Murali, Ehab Salem Yousef Al-Rayyan, Kehui Luo, Jonathan Carter, Outcome of cervical intraepithelial neoplasia 2 diagnosed by punch biopsy in 131 women, Journal of Obstetrics and Gynaecology Research, 2011, 37, 7
  35. 35
    L.-C. Horn, K. Klostermann, Präkanzerosen der Cervix uteri, Der Pathologe, 2011, 32, S2, 242

    CrossRef

  36. 36
    Mariëlle Kocken, Theo JM Helmerhorst, Johannes Berkhof, Jacqueline A Louwers, Mariëlle AE Nobbenhuis, Aagje G Bais, Cornelis JA Hogewoning, Afra Zaal, René HM Verheijen, Peter JF Snijders, Chris JLM Meijer, Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study, The Lancet Oncology, 2011, 12, 5, 441

    CrossRef

  37. 37
    Marta del Pino, Aureli Torne, Immaculada Alonso, Raquel Mula, Narcís Masoller, Victoria Fuste, Jaume Ordi, Colposcopy Prediction of Progression in Human Papillomavirus Infections With Minor Cervical Lesions, Obstetrics & Gynecology, 2010, 116, 6, 1324

    CrossRef

  38. 38
    Pluvio J. Coronado Martín, María Fasero Laiz, Mar Ramírez Mena, Clemente Arab Eblen, Mónica Bellón del Amo, Javier García Santos, José Antonio Vidart Aragón, La inmunosupresión es un factor mayor de riesgo en la recidiva de las lesiones del tracto genital inferior asociadas al virus del papiloma humano, Progresos de Obstetricia y Ginecología, 2010, 53, 5, 179

    CrossRef

  39. 39
    Dae-Hoon Jeong, Kyung-Bok Lee, Ki-Tae Kim, Management of gynecologic patients with precancerous disease, Korean Journal of Obstetrics and Gynecology, 2010, 53, 4, 291

    CrossRef

  40. 40
    Ilkka Kalliala, Tadeusz Dyba, Pekka Nieminen, Timo Hakulinen, Ahti Anttila, Mortality in a long-term follow-up after treatment of CIN, International Journal of Cancer, 2010, 126, 1
  41. 41
    J. Melnikow, C. McGahan, G. F. Sawaya, T. Ehlen, A. Coldman, Cervical Intraepithelial Neoplasia Outcomes After Treatment: Long-term Follow-up From the British Columbia Cohort Study, JNCI Journal of the National Cancer Institute, 2009, 101, 10, 721

    CrossRef

  42. 42
    Nagindra Das, Veronica Sutton, John Bevan, Dirk Brinkmann, Robert Woolas, Cytological Follow-up of Women Older than 50 Years With High-Grade Cervical Smear Treated by Large Loop Excision, Journal of Lower Genital Tract Disease, 2009, 13, 3, 165

    CrossRef

  43. You have free access to this content43
    J. Jordan, P. Martin-Hirsch, M. Arbyn, U. Schenck, J.-J. Baldauf, D. Da Silva, A. Anttila, P. Nieminen, W. Prendiville, European guidelines for clinical management of abnormal cervical cytology, Part 2, Cytopathology, 2009, 20, 1
  44. 44
    Kyehyun Nam, Sooho Chung, Jeongsig Kim, Seob Jeon, Donghan Bae, Factors associated with HPV persistence after conization in patients with negative margins, Journal of Gynecologic Oncology, 2009, 20, 2, 91

    CrossRef

  45. 45
    Yaxia Chen, Hongxian Lu, Xiaoyun Wan, Weiguo Lv, Xing Xie, Factors associated with positive margins in patients with cervical intraepithelial neoplasia grade 3 and postconization management, International Journal of Gynecology & Obstetrics, 2009, 107, 2, 107

    CrossRef

  46. 46
    Sophia Brismar, Bo Johansson, Malin Borjesson, Marc Arbyn, Sonia Andersson, Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping, American Journal of Obstetrics and Gynecology, 2009, 201, 1, 17.e1

    CrossRef

  47. 47
    Pere Fuste, Bea Bellosillo, Xavier Santamaria, Gemma Mancebo, Leisa Mariñoso, Francesc Alameda, Blanca Espinet, Francese Sole, Sergi Serrano, Ramon Carreras, HPV Determination in the Control After LEEP Due to CIN II-III: Prospective Study and Predictive Model, International Journal of Gynecological Pathology, 2009, 28, 2, 120

    CrossRef

  48. You have free access to this content48
    W. Prendiville, The treatment of CIN: what are the risks?, Cytopathology, 2009, 20, 3
  49. 49
    Jörg Schwock, Nhu-An Pham, Mary P. Cao, David W. Hedley, Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo, Cancer Chemotherapy and Pharmacology, 2008, 61, 4, 669

    CrossRef

  50. 50
    Kathryn Whitehead, Samir Mitragotri, Mechanistic Analysis of Chemical Permeation Enhancers for Oral Drug Delivery, Pharmaceutical Research, 2008, 25, 6, 1412

    CrossRef

  51. 51
    Margaret RE McCredie, Katrina J Sharples, Charlotte Paul, Judith Baranyai, Gabriele Medley, Ronald W Jones, David CG Skegg, Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study, The Lancet Oncology, 2008, 9, 5, 425

    CrossRef

  52. 52
    J.-L. Mergui, J. Levêque, Quel suivi après traitement chirurgical d’une lésion de haut grade du col utérin ?, Gynécologie Obstétrique & Fertilité, 2008, 36, 4, 441

    CrossRef

  53. 53
    J.-L. Mergui, V. Polena, E. David-Montefiore, S. Uzan, Recommandations pour la surveillance des patientes traitées pour des lésions de haut grade du col utérin, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2008, 37, 1, S121

    CrossRef

  54. 54
    Thomas C. Wright, L. Stewart Massad, Charles J. Dunton, Mark Spitzer, Edward J. Wilkinson, Diane Solomon, 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ, American Journal of Obstetrics and Gynecology, 2007, 197, 4, 340

    CrossRef

  55. 55
    Thomas C. Wright, L. Stewart Massad, Charles J. Dunton, Mark Spitzer, Edward J. Wilkinson, Diane Solomon, 2006 Consensus Guidelines for the Management of Women With Cervical Intraepithelial Neoplasia or Adenocarcinoma In Situ, Journal of Lower Genital Tract Disease, 2007, 11, 4, 223

    CrossRef

  56. 56
    E Paraskevaidis, M Kyrgiou, P Martin-Hirsch, Commentary: Have we dismissed ablative treatment too soon in colposcopy practice?, BJOG: An International Journal of Obstetrics & Gynaecology, 2007, 114, 1
  57. 57
    Sadaf Ghaem-Maghami, Shlomi Sagi, Gulnaz Majeed, William P Soutter, Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis, The Lancet Oncology, 2007, 8, 11, 985

    CrossRef

  58. 58
    L.P. Shulman, Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia, Yearbook of Obstetrics, Gynecology and Women's Health, 2007, 2007, 312

    CrossRef

  59. 59
    P Martin-Hirsch, B Rash, A Martin, B Standaert, Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales, BJOG: An International Journal of Obstetrics & Gynaecology, 2007, 114, 4
  60. 60
    Henry C. Kitchener, Philip E. Castle, J. Thomas Cox, Chapter 7: Achievements and limitations of cervical cytology screening, Vaccine, 2006, 24, S63

    CrossRef

  61. 61
    Marc Arbyn, Peter Sasieni, Chris J.L.M. Meijer, Christine Clavel, George Koliopoulos, Joakim Dillner, Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses, Vaccine, 2006, 24, S78

    CrossRef

  62. 62
    M. Kyrgiou, I. Tsoumpou, T. Vrekoussis, P. Martin-Hirsch, M. Arbyn, W. Prendiville, S. Mitrou, G. Koliopoulos, N. Dalkalitsis, P. Stamatopoulos, E. Paraskevaidis, The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: The cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach, Cancer Treatment Reviews, 2006, 32, 7, 516

    CrossRef

  63. 63
    Esther van der Heijden, Alberto D Lopes, Andrew Bryant, Ruud Bekkers, Khadra Galaal, Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test, The Cochrane Library,